Condition: Behçet's Disease · Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd
This is a phase 3, multi-center, randomized, placebo-controlled, double-blind, parallel-group study with an equal randomization among the Hemay005 high dose, lower dose and placebo treatment groups. After subject randomization, each subject will enter an core-treatment Phase for 12 weeks following an extended-treatment phase for another 40 weeks and a follow up phase for 4weeks.
This description comes directly from the study's public registry record.
Jinfeng Lin · 15790249669 · linjinfeng@hemay.com.cn
Always discuss trial participation with your own doctor first.
| Beijing Friendship hospital capital medical hospital | Beijing, Beijing Municipality, China | Recruiting |
| Peking university first hospital | Beijing, Beijing Municipality, China | Recruiting |
| Peking University People's Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Peking university third hospital | Beijing, Beijing Municipality, China | Recruiting |
| Xuanwu hospital capital medical university | Beijing, Beijing Municipality, China | Recruiting |
| The first affiliated hospital of Xiamen University | Xiamen, Fujian, China | Recruiting |
| Guangdong second provincial central hospital | Guangzhou, Guangdong, China | Recruiting |
| Sun Yat-Sen memorial hospital | Guangzhou, Guangdong, China | Recruiting |
| The third affiliated hospital sun yat-sen university | Guangzhou, Guangdong, China | Recruiting |
| The university of Hong Kong-Shenzhen Hospital | Shenzhen, Guangdong, China | Recruiting |
| Affiliated hospital of Guilin Medical university | Guilin, Guangxi, China | Recruiting |
| The second hospital of Hebei medical university | Shijiazhuang, Hebei, China | Not Yet Recruiting |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06145893